Treatment of mice with IL-1β along with retinoid-binding protein injection enhanced experimental autoimmune uveitis development, whereas treatment with an anti-IL-1β antibody attenuated the inflammatory response (Zhao et al., 2014). This evidence concerns the gene IL1B and autoimmune uveitis.